Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma

This study is ongoing, but not recruiting participants.
Information provided by Dana-Farber Cancer Institute

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Mesothelioma
2		More general conditions related to this trial
			Adenoma
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms, Glandular and Epithelial
			Neoplasms, Mesothelial
3		Interventions listed in this trial
			Erlotinib
			Bevacizumab
4		More general drug interventions related to this trial
			Angiogenesis Inhibitors
			Angiogenesis Modulating Agents
			Antineoplastic Agents
			Enzyme Inhibitors
			Growth Inhibitors
			Growth Substances
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Physiological Effects of Drugs
			Protein Kinase Inhibitors
			Therapeutic Uses
5		Sponsors listed in this trial
			Dana-Farber Cancer Institute
			Massachusetts General Hospital
			University of Chicago